A recent study has found a significant link between Benadryl’s active ingredient and an increased risk of dementia. The medication, commonly used to relieve allergies, can also cross the blood-brain barrier and affect brain cells, increasing the risk of cognitive decline.
The study, published in JAMA Internal Medicine, tracked 3,400 people over 65 years old and found that those taking antihistamines like Benadryl regularly had a 54% higher risk of dementia compared to non-users. The risk was even higher for those taking two or more doses per week.
Doctors are warning patients to be cautious when using Benadryl, particularly if they take it regularly or have pre-existing conditions such as Alzheimer’s disease. They recommend alternative medications like Zyrtec or Allegra instead.
The maker of Benadryl, Kenvue, claims that the medication is safe and effective, but experts say that the risk of dementia associated with its use outweighs any potential benefits. The FDA has issued no warning about the link between Benadryl and dementia, but doctors are advising patients to speak to their healthcare provider before taking the medication.
The US Food and Drug Administration (FDA) does not have a specific warning label on Benadryl regarding dementia risk, but the study’s findings suggest that more research is needed.
Source: https://www.dailymail.co.uk/health/article-14918501/benadryl-crippling-disease-warning.html